Overview
- 38 inspections across 38 sites are on record.
- 35 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2026-04-23.
At a glance
Inspections
38
Sites
38
Observations
35
Career since
Apr 2011
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Wyeth Pharmaceutical Division of Wyeth Holdings LLC | 23 Apr 2026 | Biologics | On file |
| Corixa Corporation | 12 Mar 2026 | Biologics | On file |
| Emergent Biodefense Operations Lansing LLC | 10 Feb 2026 | Biologics | |
| Simtra US LLC | 11 Dec 2025 | Biologics | View 483 → |
| Advanced Therapies LLC | 25 Nov 2025 | Biologics |
Sites inspected
Wyeth Pharmaceutical Division of Wyeth Holdings LLCSanford, United States1 insp.
Corixa CorporationMarietta, United States1 insp.
Emergent Biodefense Operations Lansing LLCCanton, United States1 insp.
Simtra US LLCBloomington, United States1 insp.
Advanced Therapies LLCPhiladelphia, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Richard L Bartlett5 shared
Susan M Jackson3 shared
Gene D Arcy3 shared
Meihong Liu3 shared
Lizaida Perez2 shared
Thai D Truong2 shared
Brentley S Pittman2 shared
Jeremy L Wally2 shared
Scott T Ballard2 shared
Bo Liang2 shared
Full investigator report
Get the verbatim findings behind Priscilla M Pastrana's 35 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site